We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · March 24, 2021

Outcomes Following Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal SCC

JAMA Surgery

 

Additional Info

JAMA Surgery
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
JAMA Surg 2021 Mar 17;[EPub Ahead of Print], H Wang, H Tang, Y Fang, L Tan, J Yin, Y Shen, Z Zeng, J Zhu, Y Hou, M Du, J Jiao, H Jiang, L Gong, Z Li, J Liu, D Xie, W Li, C Lian, Q Zhao, C Chen, B Zheng, Y Liao, K Li, H Li, H Wu, L Dai, KN Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading